In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics
Purpose Iron is essential for development and growth in young children; unfortunately, iron deficiency (ID) is a significant public health problem in this population. Young Child Formulae (YCF), milk-derived products fortified with iron and ascorbic acid (AA, an enhancer of iron absorption) may be g...
Gespeichert in:
Veröffentlicht in: | European journal of nutrition 2018-03, Vol.57 (2), p.669-678 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 678 |
---|---|
container_issue | 2 |
container_start_page | 669 |
container_title | European journal of nutrition |
container_volume | 57 |
creator | Christides, Tatiana Ganis, Julia Clark Sharp, Paul Anthony |
description | Purpose
Iron is essential for development and growth in young children; unfortunately, iron deficiency (ID) is a significant public health problem in this population. Young Child Formulae (YCF), milk-derived products fortified with iron and ascorbic acid (AA, an enhancer of iron absorption) may be good sources of iron to help prevent ID. Furthermore, some YCF are supplemented with prebiotics, non-digestible carbohydrates suggested to enhance iron bioavailability. The aim of our study was to evaluate iron bioavailability of YCF relative to prebiotic and AA concentrations. We hypothesised that YCF with the highest levels of prebiotics and AA would have the most bioavailable iron.
Methods
We used the in vitro digestion/Caco-2 cell model to measure iron bioavailability from 4 commercially available YCF with approximately equal amounts of iron, but varying amounts of: AA and the prebiotics fructo- and galacto-oligosaccharides. Caco-2 cell ferritin formation was used as a surrogate marker for iron bioavailability.
Results
The YCF with the highest concentration of prebiotics and AA had the highest iron bioavailability; conversely, the YCF with the lowest concentration of prebiotics and AA had the lowest. After the addition of exogenous prebiotics, so that all tested YCF had equivalent amounts, there was no longer a significant difference between YCF iron bioavailability.
Conclusion
Our results suggest that ascorbic acid and prebiotics in YCF improve iron bioavailability. Ensuring that iron is delivered in a bioavailable form would improve the nutritional benefits of YCF in relation to ID/IDA amongst young children; therefore, further exploration of our findings in vivo is warranted. |
doi_str_mv | 10.1007/s00394-016-1353-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5845627</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2053875092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-f100b046712a4465ee116799833fc87f792d9ae14f750d60e69ed9bcb697a6b03</originalsourceid><addsrcrecordid>eNp1kU9v1DAQxSMEoqXwAbggS1y4hI7t2F5fkNCKQqVKvdBDT5bjTHa9cuJgJ1v12-PVluWPxMmW5jdv5s2rqrcUPlIAdZkBuG5qoLKmXPCaP6vOacNlLRkVz09_UGfVq5x3AMC4pC-rM6Z0w1aNOK921yPZ-zlFYnPGnAccZxJ74lMcid1bH2zrg58fSZ_iQFwcBkzO20Du4zJuyHrrQ0euYhqWYJHkZZoCHkSwIw9-3pIpYevj7F1-Xb3obcj45um9qO6uvnxff6tvbr9erz_f1E4An-u-WGuhkYoy2zRSIFIqldYrznu3Ur3SrNMWadMrAZ0ElBo73bpWamVlC_yi-nTUnZZ2wM6VZZINZkp-sOnRROvN35XRb80m7o0oF5FMFYEPTwIp_lgwz2bw2WEIdsS4ZMNA8FUZrllB3_-D7uKSxmKvUFQoAEkPFD1SLsWcE_anZSiYQ5LmmKQpSZpDkoaXnnd_ujh1_IquAOwI5FIaN5h-j_6_6k_N5arG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2015700612</pqid></control><display><type>article</type><title>In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Christides, Tatiana ; Ganis, Julia Clark ; Sharp, Paul Anthony</creator><creatorcontrib>Christides, Tatiana ; Ganis, Julia Clark ; Sharp, Paul Anthony</creatorcontrib><description>Purpose
Iron is essential for development and growth in young children; unfortunately, iron deficiency (ID) is a significant public health problem in this population. Young Child Formulae (YCF), milk-derived products fortified with iron and ascorbic acid (AA, an enhancer of iron absorption) may be good sources of iron to help prevent ID. Furthermore, some YCF are supplemented with prebiotics, non-digestible carbohydrates suggested to enhance iron bioavailability. The aim of our study was to evaluate iron bioavailability of YCF relative to prebiotic and AA concentrations. We hypothesised that YCF with the highest levels of prebiotics and AA would have the most bioavailable iron.
Methods
We used the in vitro digestion/Caco-2 cell model to measure iron bioavailability from 4 commercially available YCF with approximately equal amounts of iron, but varying amounts of: AA and the prebiotics fructo- and galacto-oligosaccharides. Caco-2 cell ferritin formation was used as a surrogate marker for iron bioavailability.
Results
The YCF with the highest concentration of prebiotics and AA had the highest iron bioavailability; conversely, the YCF with the lowest concentration of prebiotics and AA had the lowest. After the addition of exogenous prebiotics, so that all tested YCF had equivalent amounts, there was no longer a significant difference between YCF iron bioavailability.
Conclusion
Our results suggest that ascorbic acid and prebiotics in YCF improve iron bioavailability. Ensuring that iron is delivered in a bioavailable form would improve the nutritional benefits of YCF in relation to ID/IDA amongst young children; therefore, further exploration of our findings in vivo is warranted.</description><identifier>ISSN: 1436-6207</identifier><identifier>EISSN: 1436-6215</identifier><identifier>DOI: 10.1007/s00394-016-1353-3</identifier><identifier>PMID: 27942845</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Ascorbic acid ; Ascorbic Acid - administration & dosage ; Ascorbic Acid - analysis ; Ascorbic Acid - metabolism ; Bioavailability ; Biomarkers - metabolism ; Caco-2 Cells ; Carbohydrates ; Chemistry ; Chemistry and Materials Science ; Child Nutritional Physiological Phenomena ; Child, Preschool ; Children ; Digestion ; Enterocytes - metabolism ; Ferritin ; Ferritins - biosynthesis ; Foods, Specialized - analysis ; galactooligosaccharides ; Hot Temperature ; human cell lines ; Humans ; in vitro studies ; Infant ; Infant Formula - chemistry ; Infant Nutritional Physiological Phenomena ; Intestinal Absorption ; Iron ; iron absorption ; Iron deficiency ; Iron, Dietary - administration & dosage ; Iron, Dietary - analysis ; Iron, Dietary - metabolism ; nutrient deficiencies ; Nutrient deficiency ; Nutrition ; Nutritive Value ; Oligosaccharides ; Oligosaccharides - administration & dosage ; Oligosaccharides - analysis ; Oligosaccharides - metabolism ; Original Contribution ; Prebiotics ; Prebiotics - administration & dosage ; Prebiotics - analysis ; Public health ; Trisaccharides - administration & dosage ; Trisaccharides - analysis ; Trisaccharides - metabolism</subject><ispartof>European journal of nutrition, 2018-03, Vol.57 (2), p.669-678</ispartof><rights>The Author(s) 2016</rights><rights>European Journal of Nutrition is a copyright of Springer, (2016). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-f100b046712a4465ee116799833fc87f792d9ae14f750d60e69ed9bcb697a6b03</citedby><cites>FETCH-LOGICAL-c503t-f100b046712a4465ee116799833fc87f792d9ae14f750d60e69ed9bcb697a6b03</cites><orcidid>0000-0002-3160-4857</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00394-016-1353-3$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00394-016-1353-3$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27942845$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Christides, Tatiana</creatorcontrib><creatorcontrib>Ganis, Julia Clark</creatorcontrib><creatorcontrib>Sharp, Paul Anthony</creatorcontrib><title>In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics</title><title>European journal of nutrition</title><addtitle>Eur J Nutr</addtitle><addtitle>Eur J Nutr</addtitle><description>Purpose
Iron is essential for development and growth in young children; unfortunately, iron deficiency (ID) is a significant public health problem in this population. Young Child Formulae (YCF), milk-derived products fortified with iron and ascorbic acid (AA, an enhancer of iron absorption) may be good sources of iron to help prevent ID. Furthermore, some YCF are supplemented with prebiotics, non-digestible carbohydrates suggested to enhance iron bioavailability. The aim of our study was to evaluate iron bioavailability of YCF relative to prebiotic and AA concentrations. We hypothesised that YCF with the highest levels of prebiotics and AA would have the most bioavailable iron.
Methods
We used the in vitro digestion/Caco-2 cell model to measure iron bioavailability from 4 commercially available YCF with approximately equal amounts of iron, but varying amounts of: AA and the prebiotics fructo- and galacto-oligosaccharides. Caco-2 cell ferritin formation was used as a surrogate marker for iron bioavailability.
Results
The YCF with the highest concentration of prebiotics and AA had the highest iron bioavailability; conversely, the YCF with the lowest concentration of prebiotics and AA had the lowest. After the addition of exogenous prebiotics, so that all tested YCF had equivalent amounts, there was no longer a significant difference between YCF iron bioavailability.
Conclusion
Our results suggest that ascorbic acid and prebiotics in YCF improve iron bioavailability. Ensuring that iron is delivered in a bioavailable form would improve the nutritional benefits of YCF in relation to ID/IDA amongst young children; therefore, further exploration of our findings in vivo is warranted.</description><subject>Ascorbic acid</subject><subject>Ascorbic Acid - administration & dosage</subject><subject>Ascorbic Acid - analysis</subject><subject>Ascorbic Acid - metabolism</subject><subject>Bioavailability</subject><subject>Biomarkers - metabolism</subject><subject>Caco-2 Cells</subject><subject>Carbohydrates</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Child Nutritional Physiological Phenomena</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Digestion</subject><subject>Enterocytes - metabolism</subject><subject>Ferritin</subject><subject>Ferritins - biosynthesis</subject><subject>Foods, Specialized - analysis</subject><subject>galactooligosaccharides</subject><subject>Hot Temperature</subject><subject>human cell lines</subject><subject>Humans</subject><subject>in vitro studies</subject><subject>Infant</subject><subject>Infant Formula - chemistry</subject><subject>Infant Nutritional Physiological Phenomena</subject><subject>Intestinal Absorption</subject><subject>Iron</subject><subject>iron absorption</subject><subject>Iron deficiency</subject><subject>Iron, Dietary - administration & dosage</subject><subject>Iron, Dietary - analysis</subject><subject>Iron, Dietary - metabolism</subject><subject>nutrient deficiencies</subject><subject>Nutrient deficiency</subject><subject>Nutrition</subject><subject>Nutritive Value</subject><subject>Oligosaccharides</subject><subject>Oligosaccharides - administration & dosage</subject><subject>Oligosaccharides - analysis</subject><subject>Oligosaccharides - metabolism</subject><subject>Original Contribution</subject><subject>Prebiotics</subject><subject>Prebiotics - administration & dosage</subject><subject>Prebiotics - analysis</subject><subject>Public health</subject><subject>Trisaccharides - administration & dosage</subject><subject>Trisaccharides - analysis</subject><subject>Trisaccharides - metabolism</subject><issn>1436-6207</issn><issn>1436-6215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU9v1DAQxSMEoqXwAbggS1y4hI7t2F5fkNCKQqVKvdBDT5bjTHa9cuJgJ1v12-PVluWPxMmW5jdv5s2rqrcUPlIAdZkBuG5qoLKmXPCaP6vOacNlLRkVz09_UGfVq5x3AMC4pC-rM6Z0w1aNOK921yPZ-zlFYnPGnAccZxJ74lMcid1bH2zrg58fSZ_iQFwcBkzO20Du4zJuyHrrQ0euYhqWYJHkZZoCHkSwIw9-3pIpYevj7F1-Xb3obcj45um9qO6uvnxff6tvbr9erz_f1E4An-u-WGuhkYoy2zRSIFIqldYrznu3Ur3SrNMWadMrAZ0ElBo73bpWamVlC_yi-nTUnZZ2wM6VZZINZkp-sOnRROvN35XRb80m7o0oF5FMFYEPTwIp_lgwz2bw2WEIdsS4ZMNA8FUZrllB3_-D7uKSxmKvUFQoAEkPFD1SLsWcE_anZSiYQ5LmmKQpSZpDkoaXnnd_ujh1_IquAOwI5FIaN5h-j_6_6k_N5arG</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Christides, Tatiana</creator><creator>Ganis, Julia Clark</creator><creator>Sharp, Paul Anthony</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RQ</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3160-4857</orcidid></search><sort><creationdate>20180301</creationdate><title>In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics</title><author>Christides, Tatiana ; Ganis, Julia Clark ; Sharp, Paul Anthony</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-f100b046712a4465ee116799833fc87f792d9ae14f750d60e69ed9bcb697a6b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Ascorbic acid</topic><topic>Ascorbic Acid - administration & dosage</topic><topic>Ascorbic Acid - analysis</topic><topic>Ascorbic Acid - metabolism</topic><topic>Bioavailability</topic><topic>Biomarkers - metabolism</topic><topic>Caco-2 Cells</topic><topic>Carbohydrates</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Child Nutritional Physiological Phenomena</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Digestion</topic><topic>Enterocytes - metabolism</topic><topic>Ferritin</topic><topic>Ferritins - biosynthesis</topic><topic>Foods, Specialized - analysis</topic><topic>galactooligosaccharides</topic><topic>Hot Temperature</topic><topic>human cell lines</topic><topic>Humans</topic><topic>in vitro studies</topic><topic>Infant</topic><topic>Infant Formula - chemistry</topic><topic>Infant Nutritional Physiological Phenomena</topic><topic>Intestinal Absorption</topic><topic>Iron</topic><topic>iron absorption</topic><topic>Iron deficiency</topic><topic>Iron, Dietary - administration & dosage</topic><topic>Iron, Dietary - analysis</topic><topic>Iron, Dietary - metabolism</topic><topic>nutrient deficiencies</topic><topic>Nutrient deficiency</topic><topic>Nutrition</topic><topic>Nutritive Value</topic><topic>Oligosaccharides</topic><topic>Oligosaccharides - administration & dosage</topic><topic>Oligosaccharides - analysis</topic><topic>Oligosaccharides - metabolism</topic><topic>Original Contribution</topic><topic>Prebiotics</topic><topic>Prebiotics - administration & dosage</topic><topic>Prebiotics - analysis</topic><topic>Public health</topic><topic>Trisaccharides - administration & dosage</topic><topic>Trisaccharides - analysis</topic><topic>Trisaccharides - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Christides, Tatiana</creatorcontrib><creatorcontrib>Ganis, Julia Clark</creatorcontrib><creatorcontrib>Sharp, Paul Anthony</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Career & Technical Education Database</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Christides, Tatiana</au><au>Ganis, Julia Clark</au><au>Sharp, Paul Anthony</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics</atitle><jtitle>European journal of nutrition</jtitle><stitle>Eur J Nutr</stitle><addtitle>Eur J Nutr</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>57</volume><issue>2</issue><spage>669</spage><epage>678</epage><pages>669-678</pages><issn>1436-6207</issn><eissn>1436-6215</eissn><abstract>Purpose
Iron is essential for development and growth in young children; unfortunately, iron deficiency (ID) is a significant public health problem in this population. Young Child Formulae (YCF), milk-derived products fortified with iron and ascorbic acid (AA, an enhancer of iron absorption) may be good sources of iron to help prevent ID. Furthermore, some YCF are supplemented with prebiotics, non-digestible carbohydrates suggested to enhance iron bioavailability. The aim of our study was to evaluate iron bioavailability of YCF relative to prebiotic and AA concentrations. We hypothesised that YCF with the highest levels of prebiotics and AA would have the most bioavailable iron.
Methods
We used the in vitro digestion/Caco-2 cell model to measure iron bioavailability from 4 commercially available YCF with approximately equal amounts of iron, but varying amounts of: AA and the prebiotics fructo- and galacto-oligosaccharides. Caco-2 cell ferritin formation was used as a surrogate marker for iron bioavailability.
Results
The YCF with the highest concentration of prebiotics and AA had the highest iron bioavailability; conversely, the YCF with the lowest concentration of prebiotics and AA had the lowest. After the addition of exogenous prebiotics, so that all tested YCF had equivalent amounts, there was no longer a significant difference between YCF iron bioavailability.
Conclusion
Our results suggest that ascorbic acid and prebiotics in YCF improve iron bioavailability. Ensuring that iron is delivered in a bioavailable form would improve the nutritional benefits of YCF in relation to ID/IDA amongst young children; therefore, further exploration of our findings in vivo is warranted.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27942845</pmid><doi>10.1007/s00394-016-1353-3</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3160-4857</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1436-6207 |
ispartof | European journal of nutrition, 2018-03, Vol.57 (2), p.669-678 |
issn | 1436-6207 1436-6215 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5845627 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Ascorbic acid Ascorbic Acid - administration & dosage Ascorbic Acid - analysis Ascorbic Acid - metabolism Bioavailability Biomarkers - metabolism Caco-2 Cells Carbohydrates Chemistry Chemistry and Materials Science Child Nutritional Physiological Phenomena Child, Preschool Children Digestion Enterocytes - metabolism Ferritin Ferritins - biosynthesis Foods, Specialized - analysis galactooligosaccharides Hot Temperature human cell lines Humans in vitro studies Infant Infant Formula - chemistry Infant Nutritional Physiological Phenomena Intestinal Absorption Iron iron absorption Iron deficiency Iron, Dietary - administration & dosage Iron, Dietary - analysis Iron, Dietary - metabolism nutrient deficiencies Nutrient deficiency Nutrition Nutritive Value Oligosaccharides Oligosaccharides - administration & dosage Oligosaccharides - analysis Oligosaccharides - metabolism Original Contribution Prebiotics Prebiotics - administration & dosage Prebiotics - analysis Public health Trisaccharides - administration & dosage Trisaccharides - analysis Trisaccharides - metabolism |
title | In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A07%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20assessment%20of%20iron%20availability%20from%20commercial%20Young%20Child%20Formulae%20supplemented%20with%20prebiotics&rft.jtitle=European%20journal%20of%20nutrition&rft.au=Christides,%20Tatiana&rft.date=2018-03-01&rft.volume=57&rft.issue=2&rft.spage=669&rft.epage=678&rft.pages=669-678&rft.issn=1436-6207&rft.eissn=1436-6215&rft_id=info:doi/10.1007/s00394-016-1353-3&rft_dat=%3Cproquest_pubme%3E2053875092%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2015700612&rft_id=info:pmid/27942845&rfr_iscdi=true |